Literature DB >> 3106405

Results of planned in-vitro fertilization programming through the pre-administration of the oestrogen-progesterone combined pill.

J Cohen, C Debache, P Solal, A M Serkine, B Achard, A Boujenah, J P Pez, X Paris, J Robert, V Loffredo.   

Abstract

The use of an oestrogen-progesterone combined pill permits the induction of ovulation in the absence of any developing follicle. Two treatments were compared. In the first, patients received no prior treatment before stimulation. In the second, combined oestrogen-progesterone treatment was given during approximately two menstrual cycles prior to stimulation. No differences between the two groups were found in relation to oocyte maturity, fertilization in vitro, cleavage, replacement and pregnancy. Fewer luteinizing hormone surges occurred in patients pre-treated with steroids. The utilization of the oestrogen-progesterone combined pill prior to induction of ovulation facilitates the forward planning of patients for in-vitro fertilization.

Entities:  

Keywords:  Anovulation; Biology; Clinical Research; Clomiphene; Contraception; Contraceptive Agents; Contraceptive Agents, Estrogen; Contraceptive Agents, Female; Contraceptive Agents, Progestin; Contraceptive Methods--therapeutic use; Demographic Factors; Developed Countries; Diseases; Economic Factors; Endocrine System; Ethinyl Estradiol; Europe; Family Planning; Fertility; Fertility Agents; France; Genital Effects, Female; Genitalia; Genitalia, Female; Gonadotropins; Gonadotropins, Chorionic; Hormones; Human Volunteers; In Vitro; Low Fertility Population; Mediterranean Countries; Menstruation Disorders; Norethindrone; Norethindrone Acetate; Oral Contraceptives, Combined--therapeutic use; Oral Contraceptives--therapeutic use; Ovarian Effects; Ovary; Ovulation; Physiology; Population; Population Dynamics; Preoperative Procedures; Reproduction; Reproductive Control Agents; Research And Development; Research Methodology; Surgery; Technology; Treatment; Urogenital Effects; Urogenital System; Western Europe

Mesh:

Substances:

Year:  1987        PMID: 3106405     DOI: 10.1093/oxfordjournals.humrep.a136491

Source DB:  PubMed          Journal:  Hum Reprod        ISSN: 0268-1161            Impact factor:   6.918


  2 in total

1.  Pretreatment with an oral contraceptive is effective in reducing the incidence of functional ovarian cyst formation during pituitary suppression by gonadotropin-releasing hormone analogues.

Authors:  M M Biljan; N G Mahutte; N Dean; R Hemmings; F Bissonnette; S L Tan
Journal:  J Assist Reprod Genet       Date:  1998-11       Impact factor: 3.412

2.  Hypothalamic-pituitary suppression with oral contraceptive pills does not improve outcome in poor responder patients undergoing in vitro fertilization-embryo transfer cycles.

Authors:  P Kovacs; P E Barg; B R Witt
Journal:  J Assist Reprod Genet       Date:  2001-07       Impact factor: 3.412

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.